VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Subject has provided informed consent              │ Subject has provided informed consent              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject is ≥ 18 years of age                       │ Subject is ≥ 18 years of age                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject is willing and able to comply with all     │ Subject is willing and able to comply with all     │     100 │
│ aspects of treatment and evaluation schedule       │ aspects of treatment and evaluation schedule       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has indeterminate, ulcerative, antibiotic- │ Subject has indeterminate, ulcerative, antibiotic- │     100 │
│ associated colitis                                 │ associated colitis                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject with other known infectious cause of       │ Subject with other known infectious cause of       │     100 │
│ abdominal symptoms                                 │ abdominal symptoms                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject with clinical evidence of renal disease    │ Subject with clinical evidence of renal disease    │     100 │
│ with the past 6 months, defined as estimated       │ with the past 6 months, defined as estimated       │         │
│ glomerular filtration rate (GFR) outside the       │ glomerular filtration rate (GFR) outside the       │         │
│ normal reference range                             │ normal reference range                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject with known history of intestinal           │ Subject with known history of intestinal           │     100 │
│ obstruction or current obstructive symptoms, such  │ obstruction or current obstructive symptoms, such  │         │
│ as severe abdominal pain with accompanying nausea  │ as severe abdominal pain with accompanying nausea  │         │
│ or vomiting, based on investigator judgment        │ or vomiting, based on investigator judgment        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject with a diagnosis of gastroparesis or small │ Subject with a diagnosis of gastroparesis or small │     100 │
│ bowel or large bowel dysmotility                   │ bowel or large bowel dysmotility                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has used non-steroidal anti-inflammatory   │ Subject has used non-steroidal anti-inflammatory   │     100 │
│ drugs including aspirin, two times per week,       │ drugs including aspirin, two times per week,       │         │
│ during the 4 weeks preceding enrollment. Low dose  │ during the 4 weeks preceding enrollment. Low dose  │         │
│ aspirin regimens (≤ 100 mg daily) are acceptable   │ aspirin regimens (< 100 mg daily) are acceptable   │         │
│ and not exclusionary                               │ and not exclusionary                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject suffers from any condition, such as        │ Subject suffers from any condition, such as        │     100 │
│ swallowing problems, that precludes compliance     │ swallowing problems, that precludes compliance     │         │
│ with study and/or device instructions              │ with study and/or device instructions              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject with cardiac pacemaker or other implanted  │ Subject with cardiac pacemaker or other implanted  │     100 │
│ electromedical device                              │ electromedical device                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has an allergy or other known              │ Subject has an allergy or other known              │     100 │
│ contraindication to the medications used in the    │ contraindication to the medications used in the    │         │
│ study                                              │ study                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject is pregnant (documented by a positive      │ Subject is pregnant (documented by a positive      │     100 │
│ pregnancy test) or is actively breast-feeding      │ pregnancy test) or is actively breast-feeding      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject is considered to be a part of a vulnerable │ Subject is considered to be a part of a vulnerable │     100 │
│ population (eg. prisoners or those without         │ population (eg. prisoners or those without         │         │
│ sufficient mental capacity)                        │ sufficient mental capacity)                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has a known contraindication to MRE or IC  │ Subject has a known contraindication to MRE or IC  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has participated in a drug or device       │ Subject has participated in a drug or device       │     100 │
│ research study within 30 days of enrollment that   │ research study within 30 days of enrollment that   │         │
│ may interfere with the subject's safety or ability │ may interfere with the subject's safety or ability │         │
│ to participate in the study                        │ to participate in the study                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has stool positive for ova and parasite    │ Subject has stool positive for ova and parasite    │      99 │
│ and for Clostridium difficile toxins within 3      │ and for Clostridium difficule toxins within 3      │         │
│ months prior to enrollment                         │ months prior to enrollment                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has any medical condition that would make  │ Subject has any medical condition that would make  │      99 │
│ it unsafe for them to participate, per             │ it unsafe for them to participate, per             │         │
│ Investigator's discretion                          │ Investigator's descretion                          │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                     │   Score │
╞════════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years                  │ Subject has provided informed consent             │      43 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Subject with ileostomy or colostomy, history of    │ Subject has stool positive for ova and parasite   │      47 │
│ total or subtotal colectomy (including those with  │ and for Clostridium difficule toxins within 3     │         │
│ ileosigmoidostomy, and ileorectostomy)             │ months prior to enrollment                        │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Subject with suspected or known bowel obstruction, │ Subject with any current condition believed to    │      49 │
│ stricture (defined as unequivocal proximal         │ have an increased risk of capsule retention such  │         │
│ upstream dilation equal ≥ 2.5 cm), or fistula      │ as suspected or known bowel obstruction,          │         │
│                                                    │ stricture, or fistula                             │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Subject has known CD and a recent history (within  │ Subject has known CD and a recent history (within │      67 │
│ last 2 years) of mucosal disease (based on         │ last 2 years) of mucosal disease (diagnosis based │         │
│ radiologic, endoscopic, or histologic evidence) OR │ on radiologic, endoscopic, or histological        │         │
│ known CD and active disease, based on clinical     │ evidence)                                         │         │
│ judgment based on symptoms, laboratory data or     │                                                   │         │
│ other clinical information                         │                                                   │         │
╘════════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒════════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                     │   Score │
╞════════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Subject with suspected or known bowel obstruction, │ Subject with any current condition believed to    │      49 │
│ stricture (defined as unequivocal proximal         │ have an increased risk of capsule retention such  │         │
│ upstream dilation equal ≥ 2.5 cm), or fistula      │ as suspected or known bowel obstruction,          │         │
│                                                    │ stricture, or fistula                             │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Subject with a diagnosis of gastroparesis or small │ Subjects with a history of small bowel or colonic │      62 │
│ bowel or large bowel dysmotility                   │ resection                                         │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Subject has known CD and a recent history (within  │ Subject has known CD and a recent history (within │      67 │
│ last 2 years) of mucosal disease (based on         │ last 2 years) of mucosal disease (diagnosis based │         │
│ radiologic, endoscopic, or histologic evidence) OR │ on radiologic, endoscopic, or histological        │         │
│ known CD and active disease, based on clinical     │ evidence)                                         │         │
│ judgment based on symptoms, laboratory data or     │                                                   │         │
│ other clinical information                         │                                                   │         │
╘════════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 90
Average Levenshtein Ratio of individual lines: 87.28
OverAll Ratio: 88.64
